Product resources library
Browse our library of Rivfloza® product education, including the Prescribing Information, dosing and administration, mechanism of action, and more.
Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg
Rivfloza® is indicated to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.
Rivfloza® is indicated to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.
Filter
PDF
Rivfloza® Prescribing Information Brochure
Explore Prescribing Information for Rivfloza®.
PDF
Rivfloza® Dosing and Administration Guide
Learn about dosing and administration for patients.
PDF
Rivfloza® Brochure
Explore key points about Rivfloza®.
PDF
Rivfloza® New-Patient Enrollment Form
Ready to prescribe Rivfloza®? Start here and access NovoCare® support services.
Rivfloza® Mechanism of Action Video
Understand how Rivfloza® works with this animated video.
Important Safety Information for Rivfloza®
Adverse Reactions
- Most common adverse reaction (reported in 39% of patients) are injection site reactions, which include erythema, pain, bruising, and rash.
Indications and Usage
Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.
Please click here for Rivfloza® Prescribing Information.